| Ortin Global Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539287 |
NSE Symbol : ORTINGLOBE |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE749B01020 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 1.60 |
Market Cap(₹Cr) : 12.51 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.01 | 0.04 | 0.05 | 0.03 | 0.05 | 0.21 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.01 | 0.04 | 0.05 | 0.03 | 0.05 | 0.21 |
| Other Operating Income | 0.00 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Total Income | 0.01 | 0.08 | 0.09 | 0.05 | 0.05 | 0.21 |
| Total Expenditure | 0.52 | 0.24 | 0.25 | 0.17 | 0.50 | 0.31 |
| PBIDT | -0.50 | -0.16 | -0.16 | -0.11 | -0.45 | -0.10 |
| Interest | 0.00 | 0.00 | 0.00 | -0.01 | 0.02 | 0.00 |
| PBDT | -0.50 | -0.16 | -0.16 | -0.10 | -0.47 | -0.10 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.50 | -0.18 | -0.16 | -0.11 | -0.47 | -0.10 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.50 | -0.18 | -0.16 | -0.13 | -0.47 | -0.10 |
| EPS (Unit Curr.) | -0.62 | -0.22 | -0.20 | -0.13 | -0.58 | -0.13 |
| EPS (Adj) (Unit Curr.) | -0.62 | -0.22 | -0.20 | -0.13 | -0.58 | -0.13 |
| Calculated EPS (Unit Curr.) | -0.62 | -0.22 | -0.20 | -0.13 | -0.58 | -0.13 |
| Calculated EPS (Adj) (Unit Curr.) | -0.62 | -0.22 | -0.20 | -0.13 | -0.58 | -0.13 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.47 | -0.86 | -0.81 | -0.53 | -2.32 | -0.51 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.47 | -0.86 | -0.81 | -0.53 | -2.32 | -0.51 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -5,000.00 | -400.00 | -320.00 | -366.67 | -900.00 | -47.62 |
| PBDTM(%) | -5,000.00 | -400.00 | -320.00 | -333.33 | -940.00 | -47.62 |
| PATM(%) | -5,000.00 | -450.00 | -320.00 | -366.67 | -940.00 | -47.62 |